Liu Tie

Title: Liu Tie: Innovator in Albumin-Fusion Protein Purification

Introduction

Liu Tie is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biochemistry, particularly in the purification of albumin-fusion proteins. With a total of 3 patents, his work has implications for enhancing the bioactivity and stability of therapeutic proteins.

Latest Patents

Liu Tie's latest patents focus on a method of purifying albumin-fusion proteins. This innovative method aims to reduce the level of oxidation of susceptible amino acid residues. The process involves an affinity matrix chromatography step followed by an anion exchange chromatography step. The resulting purified albumin-fusion proteins exhibit low levels of oxidation, which helps retain their enhanced half-life in vivo and their bioactivity. In some embodiments, the albumin-fusion protein includes a scaffold, such as the human Tenascin C scaffold. Compositions that incorporate the albumin-fusion protein are also disclosed in his patents.

Career Highlights

Throughout his career, Liu Tie has worked with prominent companies in the biotechnology sector, including MedImmune Limited. His experience in these organizations has allowed him to develop and refine his innovative techniques in protein purification.

Collaborations

Liu Tie has collaborated with several professionals in his field, including Timothy Pabst and Mariko Fonseca. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Liu Tie's work in the purification of albumin-fusion proteins represents a significant advancement in biochemistry. His innovative methods and collaborations have the potential to enhance therapeutic applications in the medical field.